Maternal Epstein-Barr virus and cytomegalovirus infections and risk of testicular cancer in the offspring: A nested case-control study

APMIS

Volumn 116, Issue 9, 2008, Pages 816-822

  Holl, Katsiaryna ^a,b   Surcel, Helja Marja ^a   Koskela, Pentti ^a   Dillner, Joakim ^c   Hallmans, Göran ^d   Wadell, Göran ^d   Kaasila, Marjo ^a   Olafsdottir, Gudridur H ^e   Ögmundsdottir, Helga M ^f,g   Pukkala, Eero ^b,h   Stattin, Pär ^d   Lehtinen, Matti ^a,b  

^a NATIONAL PUBLIC HEALTH INSTITUTE   (Finland)

^b UNIVERSITY OF TAMPERE   (Finland)

^c LUND UNIVERSITY   (Sweden)

^d UMEÅ UNIVERSITY   (Sweden)

^e ICELANDIC CANCER REGISTRY   (Iceland)

^f ICELANDIC CANCER SOCIETY   (Iceland)

^g UNIVERSITY OF ICELAND   (Iceland)

^h FINNISH CANCER REGISTRY   (Finland)

Author keywords

Cytomegalovirus; Epstein Barr virus; Maternal infection; Offspring; Testicular cancer

Indexed keywords

IMMUNOGLOBULIN G ANTIBODY;

ANTIBODY BLOOD LEVEL; ARTICLE; CANCER RISK; CASE CONTROL STUDY; CONGENITAL INFECTION; CYTOMEGALOVIRUS INFECTION; EPSTEIN BARR VIRUS; FINLAND; FIRST TRIMESTER PREGNANCY; HERPES; HUMAN; ICELAND; MATERNAL DISEASE; NEWBORN INFECTION; PRIORITY JOURNAL; PROGENY; SWEDEN; TESTIS CANCER;

ADOLESCENT; ADULT; ANTIBODIES, VIRAL; CASE-CONTROL STUDIES; CHILD; CHILD, PRESCHOOL; COHORT STUDIES; CYTOMEGALOVIRUS; CYTOMEGALOVIRUS INFECTIONS; ENZYME-LINKED IMMUNOSORBENT ASSAY; EPSTEIN-BARR VIRUS INFECTIONS; EUROPE; FEMALE; HERPESVIRUS 4, HUMAN; HUMANS; IMMUNOGLOBULIN G; INFECTIOUS DISEASE TRANSMISSION, VERTICAL; MALE; MIDDLE AGED; PREGNANCY; SEROEPIDEMIOLOGIC STUDIES; TESTICULAR NEOPLASMS; YOUNG ADULT;

EID: 57349099167     PISSN: 09034641     EISSN: 16000463     Source Type: Journal    
DOI: 10.1111/j.1600-0463.2008.00983.x     Document Type: Article

References (37)

1. Bray F, Ferlay J, Devesa SS, McGlynn KA, Møller H. Interpreting the international trends in testicular seminoma and nonseminoma incidence. Nature 2006 3 : 532 43.
2. Huyghe E, Matsuda T, Thonneau P. Increasing incidence of testicular cancer worldwide: a review. J Urol 2003 170 : 5 11.
3. Richiardi L, Bellocco R, Adami HO, Torrång A, Barlow L, Hakulinen T, et al. Testicular cancer incidence in eight northern European countries: secular and recent trends. Cancer Epidemiol Biomarkers Prev 2004 13 : 2157 66.
4. Grotmol T, Weiderpass E, Tretli S. Conditions in utero and cancer risk. Eur J Epidemiol 2006 21 : 561 70.
5. Svahn A, Berggren J, Parke A, Storsaeter J, Thorstensson R, Linde A. Changes in seroprevalence to four herpesviruses over 30 years in Swedish children aged 9-12 years. J Clin Virol 2006 37 : 118 23.
6. Iezzoni JC, Gaffey MJ, Weiss LM. The role of Epstein-Barr virus in lymphoepithelioma-like carcinoma. Am J Clin Pathol 1995 103 : 308 15.
7. Shibata D, Tokunaga M, Uemura Y, Sato E, Tanaka S, Weiss LM. Association of Epstein-Barr virus with undifferentiated gastric sarcomas with intense lymphoid infiltration. Lymphoepithelioma-like sarcoma. Am J Pathol 1991 139 : 469 74.
8. Rezk SA, Weiss LM. Epstein-Barr virus-associated lymphoproliferative disorders. Hum Pathol 2007 38 : 1293 304.
9. Lehtinen M, Koskela P, Ögmundsdottir HM, Bloigu A, Dillner J, Gudnadottir M, et al. Maternal herpesvirus infections and risk of acute lymphoblastic leukemia in the offspring. Am J Epidemiol 2003 158 : 207 13.
10. Algood CB, Newell GR, Johnson DE. Viral etiology of testicular tumors. J Urol 1988 139 : 308 10.
11. Heinzer H, Dieckmann KP, Huland E. Virus-related serology and in situ hybridization for the detection of virus DNA among patients with testicular cancer. Eur Urol 1993 24 : 271 6.
12. Shimakage M, Oka T, Shinka T, Kurata A, Sasagawa T, Yutsudo M. Involvement of Epstein-Barr virus expression in testicular tumours. J Urol 1996 156 : 253 7.
13. Mueller N, Hinkula J, Wahren B. Elevated antibody titers against cytomegalovirus among patients with testicular cancer. Int J Cancer 1988 41 : 399 403.
14. Guillou L, Estreicher A, Chaubert P, Hurlimann Kurt AM, Metthez G, et al. Germ cell tumors of the testis overexpress wild-type p53. Am J Pathol 1996 149 : 1221 8.
15. Gray A, Guillou L, Zufferey J, Rey F, Kurt AM, Jichlinski P, et al. Persistence of parvovirus B 19 DNA in testis of patients with testicular germ cell tumours. J Gen Virol 1998 79 : 573 9.
16. Rajpert-De Meyts E, Hørding U, Nielsen HW, Skakkebaek NE. Human papillomavirus and Epstein-Barr virus in the etiology of testicular germ cell tumours. APMIS 1994 102 : 38 42.
17. Avgil M, Ornoy A. Herpes simplex virus and Epstein-Barr virus infections in pregnancy: consequences of neonatal or intrauterine infection. Reprod Toxicol 2006 21 : 436 45.
18. Pass RF, Fowler KB, Boppana SB, Britt WJ, Stagno S. Congenital cytomegalovirus infection following first trimester maternal infection: Symptoms at birth and outcome. J Clin Virol 2006 35 : 216 20.
19. Lang DJ, Kummer JF. Demonstration of cytomegalovirus in semen. N Engl J Med 1972 287 : 756 58.
20. Holl K, Lundin E, Kaasila M, Grankvist K, Afanasyeva Y, Hallmans G, et al. Effect of long-term storage on hormone measurements in samples from pregnant women: the experience of the Finnish Maternity Cohort. Acta Oncol 2007 1 7. Epub ahead of print.
21. Pukkala E, Andersen A, Berglund G, Gislefoss R, Gudnason V, Hallmans G, et al. Nordic biological specimen banks as basis for studies of cancer causes and control - more than 2 million sample donors, 25 million persons years and 100 000 prospective cancers. Acta Oncol 2007 46 : 286 307.
22. Breslow NE, Day NE. Statistical methods in cancer research. Volume I. The analysis of case-control studies. Lyon : IARC Scientific Publication, 1980 121.
23. Purtilo DT, Sakamoto K. Reactivation of Epstein-Barr virus in pregnant women: social factors, and immune competence as determinants of lymphoproliferative disease - a hypothesis. Med Hypotheses 1982 8 : 401 8.
24. Bruu AL, Hjetland R, Holter E, Mortensen L, Natås O, Petterson W, et al. Evaluation of 12 commercial tests for detection of Epstein-Barr virus-specific and heterophile antibodies. Clin Diagn Lab Immunol 2000 7 : 451 6.
25. Nakamura N, Miyazaki K, Kitano Y, Fujisaki S, Okamura H. Suppression of cytotoxic T-lymphocyte activity during human pregnancy. J Reprod Immunol 1993 23 : 119 30.
26. Obel N, Høier-Madsen M, Kangro H. Serological and clinical findings in patients with serological evidence of reactivated Epstein-Barr virus infection. APMIS 1996 104 : 424 8.
27. Okano M, Thiele GM, Davis JR, Grierson HL, Purtilo DT. Epstein-Barr virus and human diseases: recent advances in diagnosis. Clin Microbiol Rev 1988 1 : 300 12.
28. Herbst H, Niedobitek G, Kneba M, Hummel M, Finn T, Anaqnostopoulos I, et al. High incidence of Epstein-Barr virus genomes in Hodgkin's disease. Am J Pathol 1990 137 : 13 8.
29. Brousset P, Meqqetto P, Chittal A, Bibeau F, Arnaud J, Rubin B, et al. Assessment of the methods for the detection of Epstein-Barr virus nucleic acids and related gene products in Hodgkin's disease. Lab Invest 1993 69 : 483 90.
30. Newell GR, Mills PK, Johnson DE. Epidemiologic comparison of cancer of the testis and Hodgkin's disease among young males. Cancer 1984 54 : 1117 23.
31. Rajpert-De Meyts E, Jorgensen N, Brondum-Nielsen K, Muller J, Skakkebaek NE. Developmental arrest of germ cells in the pathogenesis of germ cell neoplasia. APMIS 1998 106 : 198 204.
32. Skakkebaek NE, Berthelsen JG, Giwercman A, Muller J. Carcinoma-in-situ of the testis: possible origin from gonocytes and precursor of all types of germ cell tumors except spermatocytoma. Int J Androl 1987 10 : 19 28.
33. Shikamage M, Dezawa T, Tamura S, Tabata T, Aoyagi N, Koike M, et al. A Ki-1-positive cell line expressing Epstein-Barr virus antigens established from a child with Ki-1-positive lymphoma. Intervirology 1993 36 : 215 24.
34. Akre O, Lipworth L, Treili S, Linde A, Engstrand L, Adami HO, et al. Epstein-Barr virus and cytomegalovirus in relation to testicular-cancer risk: a nested case-control study. Int J Cancer 1999 82 : 1 5.
35. Eskild A, Bruu AL, Stray-Pedersen B, Jenum P. Epstein-Barr virus infection during pregnancy and the risk of adverse pregnancy outcome. BJOG 2005 112 : 1620 4.
36. Sundström P, Juto P, Wadell G, Hallmans G, Svenningsson A, Nyström L, et al. An altered immune response to Epstein-Barr virus in multiple sclerosis. Neurology 2004 62 : 2277 82.
37. Toniolo P, Boffetta P, Shuker DEG, Rothman N, Hulka B, Pearce N. Application of biomarkers to cancer epidemiology. Lyon : IARC Scientific Publication, 1997 : 142.